Charité-Universitätsmedizin Berlin, BCRT-Berlin Institute of Health (BIH) Center for Regenerative Therapies, 10178 Berlin, Germany.
Institute of Medical Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany.
Int J Mol Sci. 2019 Dec 17;20(24):6363. doi: 10.3390/ijms20246363.
Cells release extracellular vesicles (EVs) to communicate in a paracrine manner with other cells, and thereby influence processes, such as angiogenesis. The conditioned medium of human cardiac-derived adherent proliferating (CardAP) cells was recently shown to enhance angiogenesis. To elucidate whether their released EVs are involved, we isolated them by differential centrifugation from the conditioned medium derived either in the presence or absence of a pro-inflammatory cytokine cocktail. Murine recipient cells internalized CardAP-EVs as determined by an intracellular detection of human proteins, such as CD63, by a novel flow cytometry method for studying EV-cell interaction. Moreover, endothelial cells treated for 24 h with either unstimulated or cytokine stimulated CardAP-EVs exhibited a higher tube formation capability on Matrigel. Interestingly, unstimulated CardAP-EVs caused endothelial cells to release significantly more vascular endothelial growth factor and interleukin (IL)-6, while cytokine stimulated CardAP-EVs significantly enhanced the release of IL-6 and IL-8. By nCounter miRNA expression assay (NanoString Technologies) we identified microRNA 302d-3p to be enhanced in unstimulated CardAP-EVs compared to their cytokine stimulated counterparts, which was verified by quantitative polymerase chain reaction. This study demonstrates that both CardAP-EVs are pro-angiogenic by inducing different factors from endothelial cells. This would allow to select potent targets for a safe and efficient therapeutic application.
细胞通过细胞外囊泡(EVs)以旁分泌的方式释放来与其他细胞进行通讯,从而影响血管生成等过程。最近有人发现,人类心脏来源的贴壁增殖(CardAP)细胞的条件培养基可以增强血管生成。为了阐明它们释放的 EV 是否参与其中,我们通过差速离心从有或没有促炎细胞因子鸡尾酒存在的条件培养基中分离出 EV。通过一种新的研究 EV-细胞相互作用的流式细胞术方法,发现接受细胞内化了 CardAP-EV,这可以通过检测到的人类蛋白,如 CD63,来确定。此外,用未刺激或细胞因子刺激的 CardAP-EV 处理 24 小时的内皮细胞在 Matrigel 上表现出更高的管状形成能力。有趣的是,未刺激的 CardAP-EV 导致内皮细胞释放出显著更多的血管内皮生长因子和白细胞介素(IL)-6,而细胞因子刺激的 CardAP-EV 则显著增强了 IL-6 和 IL-8 的释放。通过 nCounter miRNA 表达分析(NanoString Technologies),我们发现与细胞因子刺激的 CardAP-EV 相比,未刺激的 CardAP-EV 中 microRNA 302d-3p 的表达增加,通过定量聚合酶链反应得到了验证。这项研究表明,CardAP-EV 通过诱导内皮细胞产生不同的因子而具有促血管生成作用。这将允许选择安全有效的治疗应用的有效靶点。
J Nanobiotechnology. 2019-5-27
Arterioscler Thromb Vasc Biol. 2020-8-6
Med Sci (Basel). 2024-1-3
Acta Pharm Sin B. 2023-4
Biology (Basel). 2022-1-12
Front Bioeng Biotechnol. 2019-10-23
Stem Cell Res Ther. 2019-9-23
J Nanobiotechnology. 2019-5-27
Cell Death Dis. 2018-5-1
Front Oncol. 2018-3-7
Biochim Biophys Acta Biomembr. 2018-3-16